The daily coronavirus news roundup – thursday, march 26th

An app that can help trace transmission, a 30-minute diagnostics test, and other fresh coronavirus news updates.

The coronavirus crisis is unique. Addressing it will require new ideas, new perspectives, and new voices. That’s our mission at Freethink.

In our daily “Coronavirus News Roundup,” we’re highlighting the most important stories from the frontlines of the fight against COVID-19. Stories that inform, challenge, and inspire.

Here are our must reads for today, March 26th.

1. Singapore Government to Make Its Contact-Tracing App Freely Available to Developers Worldwide

The Straits Times reports that the government of Singapore has decided to make its TraceTogether app open-source — meaning people all around the world might soon be checking their smartphones to see if they’ve come in close contact with the coronavirus.

2. New York Will Be First State to Test Treatment of Coronavirus With Blood From Recovered Patients

Experts suspect that injections of blood plasma from coronavirus survivors could prove to be an effective treatment for those still battling the illness. New York will be the first state to put that theory to the test in a trial, according to NBC News. 

3. NYU Med School Will Graduate Students Early to Help New York Fight Coronavirus

More than 30% of the U.S.’s coronavirus cases are in New York City. To help ease that strain on hospitals, New York University is letting its class of 2020 medical students graduate three months early — as long as they agree to join the local workforce, TIME reports.

4. FDA Approves More ‘Rapid’ Covid-19 Coronavirus Tests for Use on Frontlines

The FDA has granted Mesa Biotech “emergency use authorization” for its Accula SARS-CoV-2 Test, according to Forbes. The hand-held test is reportedly easy to use and delivers results from throat and nose swabs in a speedy 30 minutes.

5. Help with COVID 

On March 17, OpenAI CEO Sam Altman and several collaborators launched Help With COVID, an online marketplace designed to connect volunteers with projects designed to help combat the coronavirus outbreak — and more than 4,500 people have already signed up.

Related
When an antibiotic fails: MIT scientists are using AI to target “sleeper” bacteria
Most antibiotics target metabolically active bacteria, but AI can help efficiently screen compounds that are lethal to dormant microbes.
The threat of avian flu — and what we can do to stop it
Avian flu is infecting cows on US dairy farms, and now a person has caught it — but new research could help us avoid a bird flu pandemic.
What’s next for COVID-19 drugs?
Paxlovid may have underperformed in a new trial, but other promising COVID-19 drugs are being authorized or in the works.
New antiviral shortens COVID-19 by 1.5 days
People taking simnotrelvir, a new antiviral treatment for COVID-19, felt almost immediate symptom relief and got better 1.5 days faster.
A dietician explains “Zepbound,” the newest weightloss drug
Zepbound recently joined the list of obesity-fighting drugs administered as injections that has been approved by the FDA.
Up Next
delivery robot
Subscribe to Freethink for more great stories